HIV/AIDS Clinical Trials in New York

Showing 281-300 of 342 trials

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

NCT00004736

The purpose of this study is to see if a type of anti-HIV therapy called HAART is effective in lowering levels of HIV and boosting the immune system in HIV-infected patients with tuberculosis (TB). HIV-infected patients with TB have higher levels of HIV and lower CD4 cell counts (cells in the body that fight infection) than HIV-infected patients without TB. HAART has been effective in reducing HIV levels and increasing CD4 cells in patients without TB. However, its effects in HIV-infected patients with TB are unknown.

HIV InfectionsTuberculosis

National Institute of Allergy and Infectious Diseases (NIAID)44 participants

Los Angeles, California, United States • San Diego, California, United States • Chicago, Illinois, United States +7 more locations

COMPLETEDPHASE2< 1 mile

L-Carnitine to Treat Fatigue in AIDS Patients

NCT00079599

Patients with AIDS may develop a deficiency of the micronutrient carnitine and such a deficiency may contribute to fatigue in these patients. This study will determine whether carnitine supplementation will improve fatigue and related symptoms in carnitine-deficient patients with AIDS.

HIV InfectionsAIDS

National Institute of Nursing Research (NINR)44 participantsStarted Nov 2002

New York, New York, United States

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

L-Carnitine to Treat Fatigue in AIDS Patients

HIV/AIDS Trials in Other Cities

A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT

Computer-Assisted HIV Prevention for Young Drug Users

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

A Blood Test to Look at Cells of the Immune System in Healthy Children

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Buprenorphine and Integrated HIV Care Evaluation

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy

Heterosexual HIV Transmission Study (HATS). Prospective Cohort Study

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Other Conditions in New York